Explant of a thrombosed Watchman™ device after 48 days

Article Properties
Cite
Joseph, McTague, et al. “Explant of a Thrombosed Watchman™ Device After 48 Days”. Annals of Vascular Surgery - Brief Reports and Innovations, vol. 2, no. 4, 2022, p. 100146, https://doi.org/10.1016/j.avsurg.2022.100146.
Joseph, M., Carson, O., Michael, K., Stephanie, Y., & Donald, C. (2022). Explant of a thrombosed Watchman™ device after 48 days. Annals of Vascular Surgery - Brief Reports and Innovations, 2(4), 100146. https://doi.org/10.1016/j.avsurg.2022.100146
Joseph, McTague, Oostra Carson, Kuehene Michael, Younes Stephanie, and Crescenzo Donald. “Explant of a Thrombosed Watchman™ Device After 48 Days”. Annals of Vascular Surgery - Brief Reports and Innovations 2, no. 4 (2022): 100146. https://doi.org/10.1016/j.avsurg.2022.100146.
Joseph M, Carson O, Michael K, Stephanie Y, Donald C. Explant of a thrombosed Watchman™ device after 48 days. Annals of Vascular Surgery - Brief Reports and Innovations. 2022;2(4):100146.
Refrences
Title Journal Journal Categories Citations Publication Date
Device-related thrombus after left atrial appendage closure: incidence, predictors, and outcomes Circulation
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Medicine (General)
 2018
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial [published correction appears 2009
Left atrial appendage: structure, function, and role in thromboembolism Heart
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Medicine (General)
 427 1999
Atrial fibrillation as an independent risk factor for stroke: the Framingham study 1991
Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial Circulation
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs
  • Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system
  • Medicine: Medicine (General)
 2021
Refrences Analysis
Category Category Repetition
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system9
Medicine: Medicine (General)3
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the respiratory system2
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs2
Medicine: Dermatology1
The category Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system 9 is the most frequently represented among the references in this article. It primarily includes studies from Circulation and American Journal of Cardiovascular Disease. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Title Journal Journal Categories Citations Publication Date
Heparin/rivaroxaban Reactions Weekly 2023
Citations Analysis
The first research to cite this article was titled Heparin/rivaroxaban and was published in 2023. The most recent citation comes from a 2023 study titled Heparin/rivaroxaban. This article reached its peak citation in 2023, with 1 citations. It has been cited in 1 different journals. Among related journals, the Reactions Weekly cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year